,Keyword_1,frequency,Keyword_2,degreee
0,nerve regeneration,4,gene therapy,12
1,gene therapy,4,schizophrenia,12
2,schizophrenia,3,depression,11
3,association,3,nerve regeneration,10
4,depression,3,autism,10
5,gene delivery,2,pathway,9
6,therapy,2,bipolar disorder,8
7,combination therapy,2,combination therapy,7
8,dry needling,2,gene delivery,6
9,cancer,2,therapy,6
10,epigenetics,2,dry needling,6
11,pathway,2,transcription,6
12,bipolar disorder,2,foxp1,6
13,autism,2,splicing,6
14,inflammation,2,chd8,6
15,plasticity,2,rbfox1,6
16,pla-peg-pla,1,network,6
17,polyethylenimine,1,inflammation,6
18,cytotoxicity,1,plasticity,6
19,dna release,1,dhr,5
20,ifn-lambda 1,1,scar,5
21,plga,1,sts/ten,5
22,non-viral gene delivery,1,dress,5
23,cisplatin,1,agep,5
24,silver,1,hla,5
25,nanoparticles,1,epigenetics,5
26,curcumin,1,genetics,5
27,resistance,1,cross-disorder,5
28,fragile histidine triad,1,gene,5
29,ht1080,1,micronutrients,5
30,doxorubicin,1,adhd,5
31,mtt,1,predictors,5
32,human astrocytes,1,vitamins,5
33,oligodendrocyte progenitors,1,minerals,5
34,trichostatin a,1,treatment,5
35,cell fate,1,pla-peg-pla,4
36,anticoagulant,1,polyethylenimine,4
37,actinobacterial metabolites,1,cytotoxicity,4
38,vascular calcification,1,dna release,4
39,dhr,1,cisplatin,4
40,scar,1,silver,4
41,sts/ten,1,nanoparticles,4
42,dress,1,curcumin,4
43,agep,1,resistance,4
44,hla,1,fragile histidine triad,4
45,toxin/antitoxin,1,ht1080,4
46,modules,1,doxorubicin,4
47,type ii ta module,1,mtt,4
48,rnl ab system,1,cerebral organoids,4
49,central nervous system,1,human brain,4
50,cerebral organoids,1,stem cells,4
51,human brain,1,neurons,4
52,stem cells,1,astrocytes,4
53,neurons,1,nano-complex,4
54,astrocytes,1,targeted delivery,4
55,ischemic stroke,1,fluorescence,4
56,rehabilitation,1,antitumor,4
57,constraint-induced,1,cancer,4
58,cadmium,1,glioblastoma,4
59,immunoprotection,1,temozolomide,4
60,grass carp,1,drug resistance,4
61,ctenopharyngodon idellus,1,thioridazine,4
62,ambient fine particulate matter (pm2.5),1,autophagy,4
63,pulmonary structure and,1,ar-42,4
64,nano-complex,1,chronic myeloid leukemia,4
65,targeted delivery,1,hdacs,4
66,fluorescence,1,ho-1,4
67,antitumor,1,ros,4
68,cubital tunnel,1,biofilm,4
69,cubital tunnel syndrome,1,carbapenemase,4
70,entrapment,1,hospital effluent,4
71,intramuscular stimulation,1,plasmids,4
72,intramuscular therapy,1,carbapenem,4
73,radial,1,enhancer,4
74,anti-hepatitis c virus daa,1,brain regions,4
75,genetic variation,1,biological,4
76,hepatitis c virus,1,association,4
77,anticancer activity,1,heroin dependence,4
78,brm270 nanoparticles,1,opioid related genes,4
79,human hepatoma cancer cells,1,oprd1,4
80,genome editing,1,polymorphisms,4
81,immunotherapy,1,life,4
82,gene-environment interactions,1,znf804a,4
83,individual differences,1,cannabis,4
84,personalized,1,psychosis,4
85,electric field,1,schizotypy,4
86,keratinocytes,1,gene-environment interaction,4
87,cytochrome p450,1,enzymatic antioxidants,4
88,wound healing,1,oxidants,4
89,glioblastoma,1,immune cells,4
90,temozolomide,1,cerebellum,4
91,drug resistance,1,e2f1,4
92,thioridazine,1,electroconvulsive therapy,4
93,autophagy,1,gene expression,4
94,leukemia,1,peripheral,4
95,non coding rna,1,gene-by-environment interaction,4
96,hepatocellular carcinoma,1,stress,4
97,rna interference,1,anxiety,4
98,small,1,ptsd,4
99,breast cancer,1,ifn-lambda 1,3
100,breast cancer stem cells (bcsc),1,plga,3
101,cancer stem cells,1,non-viral gene delivery,3
102,diagnosis,1,human astrocytes,3
103,management,1,oligodendrocyte progenitors,3
104,melanoma,1,trichostatin a,3
105,forkhead box proteins,1,cell fate,3
106,viruses,1,toxin/antitoxin,3
107,diabetes mellitus,1,modules,3
108,endocrine-like cells,1,type ii ta module,3
109,hdac inhibitors,1,rnl ab system,3
110,amyotrophic lateral sclerosis (als),1,ischemic stroke,3
111,epidermal growth factor receptor,1,rehabilitation,3
112,ar-42,1,constraint-induced,3
113,chronic myeloid leukemia,1,cadmium,3
114,hdacs,1,immunoprotection,3
115,ho-1,1,grass carp,3
116,ros,1,ctenopharyngodon idellus,3
117,bacterial nanocellulose,1,cubital tunnel,3
118,gene activated matrix,1,cubital tunnel syndrome,3
119,probiotic,1,entrapment,3
120,antibiotic resistance,1,intramuscular stimulation,3
121,experimental evolution,1,intramuscular therapy,3
122,whole-genome,1,radial,3
123,cell-printing technology,1,electric field,3
124,biliary system,1,keratinocytes,3
125,3d liver-on-a-chip,1,cytochrome p450,3
126,hereditary sensory and autonomic neuropathy v,1,wound healing,3
127,nerve growth factor,1,hepatocellular carcinoma,3
128,alzheimer's disease,1,rna interference,3
129,beta-amyloid precursor protein,1,small,3
130,facial paralysis,1,diagnosis,3
131,electroacupuncture,1,management,3
132,glial,1,melanoma,3
133,ginsenoside rh2,1,diabetes mellitus,3
134,cnnm1,1,endocrine-like cells,3
135,angiogenesis,1,hdac inhibitors,3
136,prostate cancer,1,probiotic,3
137,plasmid dna,1,antibiotic resistance,3
138,poly(amidoamine) dendrimers,1,experimental evolution,3
139,gold nanoparticles,1,whole-genome,3
140,folic,1,facial paralysis,3
141,crispr delivery,1,electroacupuncture,3
142,polyethylenimine (pei),1,glial,3
143,cd-pei,1,ginsenoside rh2,3
144,biofilm,1,cnnm1,3
145,carbapenemase,1,angiogenesis,3
146,hospital effluent,1,prostate cancer,3
147,plasmids,1,plasmid dna,3
148,carbapenem,1,poly(amidoamine) dendrimers,3
149,diclofenac,1,gold nanoparticles,3
150,activated sludge,1,folic,3
151,adsorption,1,diclofenac,3
152,biotransformation,1,activated sludge,3
153,soil-plant system,1,adsorption,3
154,antibiotic resistant pathogenic bacteria,1,biotransformation,3
155,antibiotic,1,biodistribution,3
156,dna methylation,1,biohybrids,3
157,dna methyltransferases (dnmts),1,metformin,3
158,dna methyltransferase,1,nanoparticle,3
159,biodistribution,1,sex differences,3
160,biohybrids,1,somatization symptoms,3
161,metformin,1,serotonin transporter,3
162,nanoparticle,1,dna,3
163,enhancer,1,5-httlpr,3
164,brain regions,1,meta-analysis,3
165,biological,1,population-based and,3
166,adrenalectomy,1,antibiotic resistance pathogenic bacteria,3
167,ventral tegmental area,1,args,3
168,medial prefrontal cortex,1,phage therapy,3
169,chrysanthemum indicum polysaccharide,1,biochar,3
170,duck hepatitis a virus,1,canakinumab,3
171,genetics,1,interleukin 1 inhibitor,3
172,cross-disorder,1,biologics,3
173,gene,1,hyperimmunoglobulinemia,3
174,protein-kinase-ii,1,biomarkers,3
175,major depressive disorder,1,genomics,3
176,transcription,1,immunostimulory therapy,3
177,foxp1,1,metabolomics,3
178,splicing,1,toca fc,3
179,chd8,1,5-fluorocytosine,3
180,rbfox1,1,cytosine deaminase,3
181,network,1,acute ischemic stroke,3
182,heroin dependence,1,growth factor,3
183,opioid related genes,1,intra-arterial,3
184,oprd1,1,caloric restriction,3
185,polymorphisms,1,cholic acid,3
186,life,1,dna damage response,3
187,sex differences,1,acetylation,3
188,somatization symptoms,1,epigenetic factors,3
189,serotonin transporter,1,genetic factors,3
190,dna,1,gut flora,3
191,major depression,1,ultrasound radiation,3
192,cardiovascular diseases,1,neuroinflammation,3
193,energy metabolism,1,beta-secretase-1 (bace1),3
194,analysis,1,neuregulin-1 (nrg1),3
195,factor-i levels,1,clinical,3
196,major,1,childhood trauma,3
197,znf804a,1,glucocorticoid receptor,3
198,cannabis,1,fear conditioning,3
199,psychosis,1,adipose tissue,3
200,schizotypy,1,hcv,3
201,gene-environment interaction,1,hepatic,3
202,micronutrients,1,insulin resistance,3
203,adhd,1,nanogold,3
204,predictors,1,rheumatoid arthritis,3
205,vitamins,1,transcription factor,3
206,minerals,1,anticoagulant,2
207,treatment,1,actinobacterial metabolites,2
208,5-httlpr,1,vascular calcification,2
209,meta-analysis,1,central nervous system,2
210,population-based and,1,anti-hepatitis c virus daa,2
211,protein gene slc6a4,1,genetic variation,2
212,enzymatic antioxidants,1,hepatitis c virus,2
213,oxidants,1,anticancer activity,2
214,immune cells,1,brm270 nanoparticles,2
215,cerebellum,1,human hepatoma cancer cells,2
216,glucocorticoid,1,genome editing,2
217,corticotropin releasing hormone,1,immunotherapy,2
218,dexamethasone,1,gene-environment interactions,2
219,e2f1,1,individual differences,2
220,electroconvulsive therapy,1,personalized,2
221,gene expression,1,leukemia,2
222,peripheral,1,non coding rna,2
223,autism spectrum disorder,1,breast cancer,2
224,functional connectivity,1,breast cancer stem cells (bcsc),2
225,structural,1,cancer stem cells,2
226,antibiotic resistance pathogenic bacteria,1,forkhead box proteins,2
227,args,1,viruses,2
228,phage therapy,1,bacterial nanocellulose,2
229,biochar,1,gene activated matrix,2
230,idiopathic pulmonary fibrosis,1,cell-printing technology,2
231,usual interstitial pneumonia,1,biliary system,2
232,canakinumab,1,3d liver-on-a-chip,2
233,interleukin 1 inhibitor,1,alzheimer's disease,2
234,biologics,1,beta-amyloid precursor protein,2
235,hyperimmunoglobulinemia,1,crispr delivery,2
236,biomarkers,1,polyethylenimine (pei),2
237,genomics,1,cd-pei,2
238,immunostimulory therapy,1,soil-plant system,2
239,metabolomics,1,antibiotic resistant pathogenic bacteria,2
240,toca fc,1,antibiotic,2
241,5-fluorocytosine,1,dna methylation,2
242,cytosine deaminase,1,dna methyltransferases (dnmts),2
243,tumor gene therapy,1,dna methyltransferase,2
244,il-24 cytokine,1,adrenalectomy,2
245,melanoma differentiation-associated,1,ventral tegmental area,2
246,acute ischemic stroke,1,medial prefrontal cortex,2
247,growth factor,1,protein-kinase-ii,2
248,intra-arterial,1,major depressive disorder,2
249,ptcl,1,major depression,2
250,comprehensive genomic profile,1,cardiovascular diseases,2
251,targeted therapy,1,energy metabolism,2
252,berardinelli-seip congenital lipodystrophy,1,analysis,2
253,familial partial,1,factor-i levels,2
254,caloric restriction,1,major,2
255,cholic acid,1,glucocorticoid,2
256,dna damage response,1,corticotropin releasing hormone,2
257,acetylation,1,dexamethasone,2
258,epigenetic factors,1,autism spectrum disorder,2
259,genetic factors,1,functional connectivity,2
260,gut flora,1,structural,2
261,ultrasound radiation,1,tumor gene therapy,2
262,neuroinflammation,1,il-24 cytokine,2
263,beta-secretase-1 (bace1),1,melanoma differentiation-associated,2
264,neuregulin-1 (nrg1),1,ptcl,2
265,clinical,1,comprehensive genomic profile,2
266,gene-by-environment interaction,1,targeted therapy,2
267,stress,1,ff,2
268,anxiety,1,ska2 methylation,2
269,ptsd,1,peripheral-blood,2
270,receptor gene,1,ambient fine particulate matter (pm2.5),1
271,ff,1,pulmonary structure and,1
272,ska2 methylation,1,amyotrophic lateral sclerosis (als),1
273,peripheral-blood,1,epidermal growth factor receptor,1
274,childhood trauma,1,hereditary sensory and autonomic neuropathy v,1
275,glucocorticoid receptor,1,nerve growth factor,1
276,fear conditioning,1,chrysanthemum indicum polysaccharide,1
277,adipose tissue,1,duck hepatitis a virus,1
278,hcv,1,protein gene slc6a4,1
279,hepatic,1,idiopathic pulmonary fibrosis,1
280,insulin resistance,1,usual interstitial pneumonia,1
281,nanogold,1,berardinelli-seip congenital lipodystrophy,1
282,rheumatoid arthritis,1,familial partial,1
283,transcription factor,1,receptor gene,1
